DNA-encoded chemical library

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Kymera

Retrieved on: 
Tuesday, January 14, 2020
Health, Biotechnology, Health sciences, Pharmaceutical sciences, Life sciences, Drug discovery, Biotechnology, Combinatorial chemistry, DNA-encoded chemical library, Molecular biology, Medication, Small molecule, Kymera Therapeutics, Inc., HitGen Inc.

HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Kymera Therapeutics, Inc., to identify small molecule leads against targets of interest to Kymera.

Key Points: 
  • HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Kymera Therapeutics, Inc., to identify small molecule leads against targets of interest to Kymera.
  • Under the terms of the agreement, HitGen will receive an undisclosed upfront payment and will be eligible for milestone payments from Kymera.
  • We look forward to working with Kymera to generate lead compounds for their research programs to help bring transformative medicines to patients.
  • HitGen has established an industry-leading platform for early-stage drug discovery research centered on DNA encoded chemical libraries (DELs).

HitGen Announces Strategic Collaboration with Janssen to Design and Build Novel DNA-Encoded Libraries

Retrieved on: 
Monday, December 9, 2019
Health, Clinical trials, Research, Pharmaceutical, Science, Biotechnology, Companies, Life sciences, Industries, Janssen Pharmaceutica, Johnson & Johnson, Janssen Biotech, Janssen, DNA-encoded chemical library

HitGen Inc. (HitGen) is pleased to announce that the company has entered into a strategic collaboration with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to design and build novel DNA-encoded libraries (DELs) to discover unique small molecule assets.

Key Points: 
  • HitGen Inc. (HitGen) is pleased to announce that the company has entered into a strategic collaboration with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to design and build novel DNA-encoded libraries (DELs) to discover unique small molecule assets.
  • The collaboration will apply HitGens advanced technology platform and research capabilities in the design and synthesis of multiple proprietary DELs for Janssen drug discovery and development efforts.
  • We look forward to working closely with Janssen to design and build proprietary DELs to support the discovery of a new generation of medicines to address unmet clinical challenges.
  • HitGen has established an industry-leading platform for early-stage drug discovery research focused on DNA encoded chemical libraries (DELs).

Oligonucleotide Synthesis - Global Market Insights & Projections to 2027 with Performance Analysis of Key Players: Thermo Fisher & Genscript - ResearchAndMarkets.com

Retrieved on: 
Monday, May 20, 2019
Health, Other Health, Branches of biology, Biology, Life sciences, Biotechnology, Molecular biology, Molecular genetics, Nucleic acids, Bioinformatics, Oligonucleotide synthesis, Oligonucleotide, Synthetic biology, DNA-encoded chemical library

The "Oligonucleotide Synthesis Market to 2027- Global Analysis and Forecasts By Product, Application, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Oligonucleotide Synthesis Market to 2027- Global Analysis and Forecasts By Product, Application, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018.
  • On the other hand, advancements in synthetic biology is likely to have a positive impact on the growth of the global oligonucleotide synthesis market in the coming years.
  • In 2018, the synthesized oligonucleotides segment held a largest market share of 48.3% of the oligonucleotide synthesis market, by product.

The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018

Retrieved on: 
Wednesday, April 17, 2019
Branches of biology, Molecular biology, Biology, Biochemistry, Nucleic acids, Oligonucleotide synthesis, Oligonucleotide, Biotechnology, Gene expression, DNA-encoded chemical library

NEW YORK, April 17, 2019 /PRNewswire/ -- The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018.

Key Points: 
  • NEW YORK, April 17, 2019 /PRNewswire/ -- The global oligonucleotide synthesis market is expected to reach US$ 3,971.72 Mn in 2027 from US$ 1,584.16 Mn in 2018.
  • Global oligonucleotide synthesis market, based on product was segmented into synthesized oligonucleotides, reagents, and equipment.
  • In 2018, the synthesized oligonucleotides segment held a largest market share of 48.3% of the oligonucleotide synthesis market, by product.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the oligonucleotide synthesis market.

Global Oligonucleotide Synthesis Market 2018-2023: Technological Advancements In Oligonucleotide Synthesis Products Driving the Market

Retrieved on: 
Thursday, August 30, 2018
Biology, Nucleic acids, Molecular biology, Oligonucleotide synthesis, Biochemistry, Oligonucleotide, Chemistry, Biotechnology, Microarrays, FlexGen, DNA-encoded chemical library

Based on offering, the oligonucleotide synthesis market is classified into synthesized oligonucleotides, reagents and consumables, and equipment.

Key Points: 
  • Based on offering, the oligonucleotide synthesis market is classified into synthesized oligonucleotides, reagents and consumables, and equipment.
  • Based on application, the oligonucleotide synthesis market is categorized into research, diagnostics, and therapeutics.
  • Academic research institutes are expected to continue holding the largest share in the oligonucleotide synthesis market in the coming years.
  • Rising geriatric population is also driving the growth of the oligonucleotide synthesis market in APAC.